ECL vs GANX · P/E 35, rev $8.48B vs $53.0M cap
Ecolab Inc (ECL) versus Gain Therapeutics Inc (GANX) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
GANX does not have a complete income-statement cache yet.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. GANX currently screens at market cap $53.0M.
Not investment advice. Open the ECL and GANX stock pages for the full models.
Not investment advice.